|
VRDN Viridian Therapeutics Incde 1590750 |
| Balance Sheet |
|
Current Assets
|
738,461,000 |
|
Assets
|
742,403,000 |
|
Current Liabilities
|
47,874,000 |
|
Liabilities
|
70,764,000 |
|
Equity
|
671,639,000 |
|
Shares Out
|
63,890,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-232,319,000 |
|
Investing Cash Flow
|
-228,651,000 |
| Market Analysis |
Market Cap
|
1,622,358,450 |
|
Price
|
15.72 |
|
BVPS
|
10.51 |
|
PB
|
1.45 |
|
EPS
|
-4.25 |
|
PS
|
1343.01 |
|
FCF
|
-460,970,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VRDN documents filed with the SEC.
VRDN Filings
Clear
